Clinical Trial Update: ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ARGX-117 in deceased donor kidney transplant recipients at risk for delayed graft function is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function

Drugs mentioned

• ARGX-117

Snippet

Sponsor: argenx | Conditions: Delayed Graft Function | Phase 2 | Status: ACTIVE_NOT_RECRUITING